Latest filing published 11 Jun 2025 for Annovis Bio, Inc., €5,158.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Reid McCarthy: trading record in brief
This profile gathers the share dealings of Reid McCarthy in Annovis Bio, Inc. We count 5 filings; the first trade dates from 19 August 2021 and the latest from 10 June 2025.
The open-market record is one-sided, with 1 purchase worth €16k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
The latest filing, published on 11 June 2025, reports a share grant of €5,158 in Annovis Bio, Inc. The clock since the last published purchase (23 August 2021) now reads 1,905 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Reid McCarthy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$2.9516.5% of flowCommon StockSEC:0001104659-25-058521:0
- 00Common StockSEC:0001104659-23-120765:0
- 824 shares@ US$6.0710.8% of flowCommon StockSEC:0001104659-23-120305:0
- 476 shares@ US$12.6113.0% of flowCommon StockSEC:0001104659-23-044203:0
- 500 shares@ US$37.6151.4% of flowCommon Stock, $0.0001 par valueSEC:0001104659-21-108434:0Canonical exit: 17 Nov 2021 (T+90)
5 of 5 declarations